LED Light Therapy Mask (4D Glow Mask FM19-0K, 4D Glow Mask FM19-1K, 4D Glow Mask FM19-2K, 4D Glow Mask FM19-VK, 4D Glow Mask FM35-0K, 4D Glow Mask FM35-1K, 4D Glow Mask FM35-2K, 4D Glow Mask FM35-VK)
Guangdong Newdermo Biotech Co., Ltd. · Decision date Nov 4, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-11-04 for K262781, a traditional 510(k) submitted by Guangdong Newdermo Biotech Co., Ltd. The device is listed as an LED Light Therapy Mask under the 4D Glow Mask name, with model designators FM19-0K, FM19-1K, FM19-2K, FM19-VK, FM35-0K, FM35-1K, FM35-2K and FM35-VK. The application was received on 08/06/2026 and falls under regulation 878.4810, product code OHS, in the General & Plastic Surgery specialty.
SESE means the submission was cleared as substantially equivalent to a predicate; it is not a PMA approval. The record shows no third-party review, no combination product status and no authorized predetermined change control plan. The public page does not state the predicate device, the specific model differences, or any clinical or performance data supporting equivalence, so those points remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Nov 4, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262781
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Guangdong Newdermo Biotech Co., Ltd.
- Product code
- OHS
- Decision code
- SESE
- Decision date
- Nov 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light Based Over The Counter Wrinkle Reduction.
- Applicant
- Guangdong Newdermo Biotech Co., Ltd.
- Product code
- OHS
- FDA device class
- 2
FDA decision timeline
K262781 received
Application receipt date recorded by FDA.
K262781 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OHS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shenzhen Bway Tech Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Shenzhen Xinlong Precision Plastic Mold Products Co., Ltd. | 510(k) clearance | Oct 23, 2026 | FDA | |
| Shenzhen Accompany Technology Co., Ltd. | 510(k) clearance | Oct 19, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Guangdong Newdermo Biotech Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Guangdong
Sources and methodology
- Original FDA record: K262781
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

